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Pulmonary Response to Hyperoxia:
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Animals and humans rapidly develop respiratory failure and die within a few days when exposed to 100% oxygen. Postmortem examination of the
lungs shows histopathologic features characteristic of diffuse alveolar damage, clinically recognized as adult respiratory distress syndrome (ARDS).
At the present time, there is no effective therapy available to alter outcomes in ARDS. Importantly, hypomagnesemia also is frequently observed in
critically ill patients at risk of developing ARDS. In a model of hyperoxic lung injury, rats were exposed to 100% oxygen for 48, 64, and 96 hr and sev-
eral experiments were performed. First, changes in the features of bronchoalveolar lavage and in alveolar macrophage function were compared in
rats exposed to room air and those exposed to hyperoxia. Second, we studied the effect of hypomagnesemia on the severity of hyperoxic lung
injury. Third, we evaluated the pulmonary responses to high-dose and normal-dose Mg therapy in rats exposed to hyperoxia. In all groups, hyperoxia
induced significant changes in the total and differential cell counts with increased lipid peroxidation of lavaged cells, enhanced chemiluminescence
from alveolar macrophages, and protein leakage into the alveolar spaces. After 48 hr of hyperoxia, oxygen-free radical formation and hydrogen per-
oxide production by the alveolar macrophage were diminished compared to baseline, implying a toxic effect of hyperoxia on the alveolar
macrophages. Overall, hypomagnesemia tended to magnify the degree of hyperoxic lung injury, while high-dose Mg therapy tended to attenuate
the effects of hyperoxia. In conclusion, in this animal model of diffuse alveolar damage, alterations in host serum magnesium levels may modulate
the degree of lung damage. - Environ Health Perspect 102(Suppl 10):101-105 (1994)
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Introduction
Many clinical conditions, including septic
shock and sepsis syndrome, lung contu-
sion, skeleton fractures with fat emboli,
bacterial lipopolysaccharide release, acute
pancreatitis, gastric aspiration, and inhala-
tion of toxic gases such as nitric oxide and
ozone, are associated with acute lung injury
or adult respiratory distress syndrome
(ARDS). The clinical and histopathologic
changes of lung injury produced by these
agents are indistinguishable from the
changes seen in hyperoxic lung injury.
Excessive pulmonary exposure to these oxi-
dant gases results in peroxidative damage
to pulmonary membranes with biochemi-
cal and metabolic changes in lung tissue
(1-10). In humans, the histologic features
of these injuries are described as diffuse
alveolar damage, and the resultant clinical
presentation ofhypoxemia, increased phys-
iologic shunt, and diminished pulmonary
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compliance are associated with such
injuries and are known as adult respiratory
distress syndrome. In the animal model of
acute inhalation injury of interest in this
report, exposure of rats to high doses of
oxygen for an extended time induces dif-
fuse alveolar damage reflective ofthe histo-
logic findings of ARDS. Despite recent
progress in understanding the pathophysi-
ology ofARDS (11-13), effective therapy
remains elusive (1,2,13).
Magnesium (Mg) plays an important
role in various metabolic processes such as
oxidative phosphorylation and cellular
enzymatic reactions. Magnesium deficiency
(MgL) is frequently observed in intensive
care unit patients and can be associated
with important and potentially life-threat-
ening adverse reactions, including cardiac
arrhythmias and insufficiency, muscle
weakness, and seizures (14,15). On a cellu-
lar level, magnesium sulfate (MgSO4)
modifies the formation ofarachidonic acid
(AA) metabolites, important mediators of
acute lung injury. Overall, Mg may
significantly affect lung structure and
mediator reactions. Examples where high
dose magnesium (MgHD) supplementation
has been effective include the therapy of
eclampsia and pre-eclampsia, tetanus, and
severe bronchospasm (16-18). The
influence ofhigh or low serum levels ofMg
on the histologic effects ofhyperoxic lung
injury is not known.
We hypothesized that supplemental
Mg therapy attenuates diffuse alveolar
damage in a rat model of lung injury due
to hyperoxia. Our intent was to develop an
effective pharmacologic treatment for dif-
fuse alveolar damage, the histologic feature
ofARDS. The specific aims were to a) fur-
ther characterize early biochemical changes
of the bronchoalveolar lavagate (BAL) and
in alveolar macrophage (AM) function due
to hyperoxia; b) determine if MgL predis-
poses rats to hyperoxic lung injury; and c)
investigate whether MgHD therapy attenu-
ates hyperoxic lung injury. Changes in pul-
monary histopathology in the rat lung
receiving MgHD also were evaluated.
Methods and Results
Changes inBronchoalveolarLavagate
Parameters andAlveolarMacrophage
Functiondueto Hyperoxia
Pulmonary hyperoxic injury was induced in
rats (19,20). Thirty-two male, specific
pathogen-free Sprague-Dawley rats (300 ±
25 g) (Hilltop Laboratory Animals Inc.,
Scottdale, PA) were housed in anAAALAC-
approved animal facility. The rats were
divided randomly and exposed to an envi-
ronment of>95% oxygen (n=18) or room
air (RA) (n =14). Hyperoxic exposure was
conducted byplacing four rats into a sealed
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plexiglass chamber constructed with parti-
tions to provide an individual compartment
for each animal. Oxygen concentrations in
the chamber were monitored using an oxy-
gen analyzer (Model 04066, Instrumentation
Lab, Lexington, MA). Animals were pro-
vided regular rat chowand water adlibitum.
Disruptions in the oxygen-rich environment
occurred only during momentary periods
ofwater and food replacement. All rats sur-
vived 64 hr ofhyperoxia.
Immediately following exposure, rats
were sacrificed and the lungs lavaged 10
times with 8 ml of Ca2+- and Mg2 -free
phosphate-buffered medium. Approximately
90% of the solution was recovered. The
first lavage samples were maintained sepa-
rate from the others. The cell pellets from
the BAL of each rat were combined for
analysis ofcell counts and functional studies.
The first supernatant was used to measure
lavage protein and phospholipid (19). We
measured
* total and differential cell counts, cell
viability, and membrane integrity;
* reduced and oxidized cellular glutathione
levels;
* cellular lipid peroxidation;
* H20 release from AM;
* chemiluminescence (CL) generated by
AM;
* cell spreading and morphometry ofAM
(analysis ofcell diameter and perimeter);
* production of oxygen-free radical (FR)
species by AM using an electron spin
resonance (ESR) technique with a radical
spin trap;
* protein and phospholipid content;
* effect ofthe addition ofsuperoxide dis-
mutase (SOD), catalase, indomethacin,
or A63162 to BAL cells to define the
contribution of superoxide, H202,
cyclooxygenase products, or lipoxyge-
nase metabolites to macrophage-gener-
ated CL.
The results were expressed as mean
± SE of the separate experiments. Data
from the exposed rats were compared to
values from controls using a Student's
t-test with significancep<0.05.
Significant changes in lung cells har-
vested by BAL were observed in the hyper-
oxic rats (19). Total cell count was
15.8x 106 per control rat versus 12.3x 106
per hyperoxic-exposed rat, a decrease of
20% following hyperoxic exposure. In the
control rats, 86% ofthe BAL cells wereAM,
6% were red blood cells, 5% were neu-
trophils, and 2% were lymphocytes. In the
hyperoxic-exposed animals, 40% were AM,
31% were red blood cells, 12% were neu-
trophils, and 15% were lymphocytes. AM
viability was reduced by 12% (from 92 to
80%) after hyperoxia. Oxidant-induced
lung injury resulted in a significant elevation
(from 0.29 ± 0.03 - 1.67 ± 0.54 mg/ml) in
the protein content of the acellular lavage
fluid. In contrast, no significant change in
lavage phospholipid content was seen. There
was no significant effect on cell spreading,
measured as the circumference ofAM adher-
ingtocoverslips, attributable tohyperoxia.
We studied the alteration in AM func-
tion due to oxidant injury by measuring
H202 release, oxygen-FR production, and
CL generation (19). The resting release of
H202 from AM was unaffected by hyper-
oxia; however, the ability ofAM to secrete
H202 in response to unopsonized zymosan
significantly decreased by 41%. Similarly,
the production ofoxygen FR by zymosan-
stimulated AM decreased 53% after oxygen
exposure. Because the decrease in reactive
oxygen species far exceeded the decrease in
AM viability, cell death cannot account for
this decrease in macrophage function.
Resting CL from AM was unchanged,
yet oxygen-exposed AM generated 540%
more CL in response to zymosan than con-
trols, even though H202 on FR production
decreases. This discrepancy is not the result
of a decrease in cellular antioxidants, since
the levels of cellular reduced and oxidized
glutathione were unaffected by hyperoxia.
This may not be totally unexpected, since
upregulation of antioxidant systems has
been known to occur after oxidant exposure.
Activation of cyclooxygenase and
lipoxygenase products of AA metabolism
has been demonstrated in ozone-exposed
AM (21). AA metabolites can generate CL
(22). To determine ifthis was the source of
the enhanced CL, the BAL cells were
treated with SOD, catalase, indomethacin,
or A63162 to block superoxide-, H202-,
cyclooxygenase-, or lipoxygenase-based CL,
respectively. Inhibitors of lipoxygenase or
cyclooxygenase were not more effective in
depressing CL after hyperoxia, while the
effectiveness of SOD or catalase did not
decrease after oxygen exposure. Therefore,
a shift from oxygen-based to arachidonic
acid-based reactive species cannot explain
the increase in CL after hyperoxia. It is
possible that the elevated levels ofCL after
oxygen exposure resulted from enhanced
cellular lipid peroxidation (23). Our data
support this, since cellularlipidperoxidation
more than doubled as a result ofhyperoxia.
RelationshipbetweenHyponmagnesemia
andAcuteHyperoxicInjury
Pulmonary hyperoxic injury was induced in
26 rats by exposure to 100% oxygen for 48
hr. MgL (serum Mg <0.7 mEq/l) was
induced in 16 rats by a Mg-deficient (Mg =
40 mcg/g) diet (TD 90278, Wayne
Laboratory Diets, Madison WI) given for 3
weeks. Eight rats were exposed to 100%
02 for 48 hr and eight served as controls
on RA. In addition, five rats on a normal
diet (Mg = 400 mcg/g) were exposed to
100% 02 for 48 hr and five served as con-
trols on RA. All animals survived 48 hr of
hyperoxia. Serum Mg levels were moni-
tored at the start and at the time of
sacrifice. BAL assessment was carried out at
the time ofsacrifice (24).
The mean serum Mg level in the MgL
diet group was 0.6 mEq/l (range 0.4-0.7
mEq/l) compared to a mean of 1.7 mEq/l
(range 1.1-2.1 mEq/l) in the group of rats
ingesting a regular diet.
Results from RA-exposed rats with nor-
mal serum Mg level were compared to RA-
exposed rats with MgL serum level. BAL
comparison showed no significant changes
in total or differential cell count, protein
content, CL, or cell viability.
BAL features of hyperoxic and RA rats
with normal serum Mg level were compared.
Statistically significant (p<0.05) changes in
the differential cell count (increased RBC
and lymphocytes) occurred after hyperoxia.
In addition, elevated protein and CL were
noted in the hyperoxic rats.
BAL features of hyperoxic rats with
MgL and normal Mg level were compared.
Hypomagnesemia significantly increased
protein levels in the BAL ofhyperoxic rats.
Compared to hyperoxic normal Mg rats,
AM and total cells were decreased by 48
and 42%, respectively, in the hyperoxic
MgL group. The increase in CL from the
RA baseline was also maximal, 530% at
rest and 350% postzymosan stimulation, in
the hyperoxic MgL group.
High-doseMgSO4 and a
HyperoxiaModel
Two studies were undertaken using this
model. First, we addressed the effect of
MgSO4 loading in a rat model of oxygen
toxicity. Second, to show the interaction
between MgSO4 and arachidonate, an in
vitro experiment was performed mixing
varying concentrations of MgSO4 with
arachidonate.
Thirty-four rats weighing 400± 15 g
were divided into three groups. Eighteen
rats in the control group (C) received no
MgSO4 supplementation. Sixteen rats were
further divided into two groups and given
MgSO4 subcutaneously in a dosing regimen
aimed at maintaining plasma Mg levels
between 4 and 6 mEq/l. Eight rats received
Environmental Health Perspectives 102HYPEROXIA ANDEFFECTS OFMAGNESIUM
low-dose (LD) MgSO4 (1.6-3.6 mEq/day)
supplementation and eight received high-
dose (HD) MgSO4 (7.2-9.6 mEq/day).
The total dose varied from 18 to 24
mEq/kg/day. Each rat had a catheter
placed in the femoral artery to allow for
sampling of blood for the measurement of
plasma Mg levels. Rats were then exposed
to 100% 02; after death the lungs were
removed for histopathologic examination
and a quantitative lung injury score was
made based on the severity of damage.
Each specimen was graded from 0 to 4 on
a severity grading scale: 0=none, 1 =mini-
mal, 2 = mild, 3 = moderate, or 4 = severe
lung damage. The lung damage scores were
expressed as the mean ± SEM and com-
pared by analysis of variance. The results
were considered significantly different at
p<0.05. Duncan's multiple range test was
also used to identify differences among
groups. For the in vitro experiment, a solu-
tion of sodium arachidonate in a concen-
tration of 2.0 mEq/l was mixed with
MgSO4 in concentrations of 0.5, 1.0, and
2.0 mEq/l. Turbidity was assessed by visual
inspection.
In rats receiving the LD Mg supple-
mentation, the mean plasma peak Mg level
(4.5 mEq/l) was in the desired range (4-6
mEq/l), but the mean plasma trough level
(1.6 mEq/l) fell far below the desired
range. In this group, the doses ofMg sup-
plementation were small and infrequent,
delivered every 8 to 12 hr. The mean
plasma peak Mg (5.3 mEq/l) and trough
(3.5 mEq/l) levels in the HD group were
in the desirable range.
The pulmonary histology showed Mg
dose-dependent changes of diffuse alveolar
damage (20). Prolonged hyperoxic expo-
sure resulted in extensive morphologic lung
damage (Figure 1) in the C group (mean
score 3.38) and considerably less damage in
the HD group (mean score 1.57) (Figure
2). The histopathology score for the HD
group indicates better preservation oflung
compared to the C group (p=0.0008). The
LD group had a mean score of 2.75,
between HD and C. This intermediate
value in the group receiving intermediate
doses ofMg supplementation validates our
approach and adds significance to the
pathology scoring.
In an accompanying in vitrostudy, avery
opaque solution formed with the 2 mEq/l
MgSO4. This was less marked when the 1
mEq/l MgSO4 solution was added. No
turbidity was seen with 0.5 mEq/l solution.
Discussion
These investigations describe changes in
Figure 1. Histopathology of control Mg hyperoxic lungs. High-power photomicrograph of the lung showing fea-
tures of diffuse alveolar damage. These include inflammatory cells in the interstitial and alveolar spaces, sloughed
alveolar epithelial cells, and hyaline membranes.
Figure 2. Histopathology of high-dose Mg hyperoxic lungs. High-power photomicrograph of the lung showing
greatly preserved lung parenchyma with a minimal number of inflammatory cells, negligible amounts of blood in
the alveolar space, and only occasional sloughed alveolar epithelial cells.
the BAL cellular and supernatant response,
as well as histologic alterations resulting
from hyperoxic exposure ofrats. Hyperoxia
resulted in an increase in the number of
neutrophils, red blood cells, and lympho-
cytes. The amount ofprotein in the alveo-
lar space was also increased. In contrast,
the number of recoverable alveolar
macrophages decreased. Histologically,
these features correlated well with the
histologic features of diffuse alveolar dam-
age. Tsan et al. (25) reported similar shifts
in lavagate cell differential counts after a
55-hr exposure of rats to 100% oxygen.
Likewise, rats exposed to 1 to 2 ppm ozone
for 4 to 8 hr showed an increased number
of lavagable neutrophils and a decreased
number of AM (26,27). In these reports,
as well as in our own work, the decreased
AM yield is likely the result of a toxic gas
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effect. The increase in lavagable neu-
trophils, red blood cells, and the elevated
amounts ofalveolar protein reflects the loss
ofthe integrity ofthe pulmonary blood/air
barrier. Protein and cellular changes suggest
capillary leak due to oxidant-induced lung
injury (diffuse alveolar damage).
A significant decline in zymosan-
induced production of H202 and oxygen
radicals by pulmonary AM suggests a
depression in AM function due to hyper-
oxia. Similarly, declines in superoxide
release from pulmonary phagocytes have
been reported following both in vitro and
in vivo exposure to ozone as well as in vivo
exposure to nitrogen dioxide (26-29).
Production ofreactive oxygen species plays
a role in the antibacterial activity ofAM.
Exposure to oxidants has been shown to
increase the susceptibility to inhaled infec-
tious agents (30).
Hyperoxia, regardless of Mg level,
caused an increased CL at rest and with
zymosan stimulation compared to the RA
group. This was most evident in the MgL
hyperoxic group (p<0.05). In contrast, CL
from the pulmonary AM was not
significantly affected by hypomagnesemia
in normoxic rats. We have previously
shown that the abnormal CL is due to
enhanced lipid peroxidation and indicates
oxidant-induced injury (19). Banks et al.
(10) reported elevated levels of CL from
both resting and stimulated AM after in
vitro exposure to ozone, while Esterline et
al. (26) found elevated CL from TPA- or
zymosan-stimulated phagocytes after in
vivo exposure to ozone. Therefore, our data
suggest that hypomagnesemia predisposes
rats to an earlyacute hyperoxic lung disease.
In this model of oxygen toxicity, HD
Mg therapy (18-24 mEq/kg/day of
MgSO4), which achieved plasma levels of4
to 6 mEq/l, reduced lung injury. Although
we have not identified the mechanism of
action of Mg in this setting, literature
review and the briefly described in vitro
experiment suggest that Mg has the poten-
tial to affect AA metabolism. This in vitro
experiment simply shows binding between
arachidonate and Mg. The reaction
between sodium oleate and differing con-
centrations of MgSO4 results in the dose-
dependent formation of a water-insoluble
complex of Mg oleate. If Mg binds to
arachidonate, this would lead to decreased
levels of AA metabolites, products well
described to cause lung injury. At high
concentrations, Mg alters the metabolism
of long chain fatty acids. On a cellular
level, Mg could alter phagocyte and vascu-
lar endothelium function. Additional
experiments are necessary to understand
the mechanism ofMg on the cellular level.
In summary, hypomagnesemia predis-
posed animals to hyperoxic lung injury,
while hypermagnesemia attenuated hyper-
oxic lung injury in our animal model.
Alteration in BAL parameters, AM function,
and pulmonary histology provided a very
consistent relationship between the degree of
lung injury due to hyperoxia and ameliora-
tion ofthis injurywith Mgsupplementation.
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